Biodefense market garnered a revenue of USD 6.3 billion in the year 2021 globally and has been foreseen to yield USD 7.9 billion by the year 2029 at a compound annual growth (CAGR) of 4.0% over the forecast period. The market has been observed to be growing at a steady growth rate over the last three years, however with the impact of COVID-19 pandemic globally, the business conditions are expected to change. The market size may reduce significantly or increase with a spike depending on how the value chain has been affected in the entire process.
Players that are operational in the market for a longer period of time are anticipated to absorb the sudden changes, losses and increased operational costs better than those who have recently entered the market. The report focuses on numerous factors that are anticipated to impact the market growth directly and indirectly. The report categorically analyses the growth patterns of different segments based on multiple derivation models.
Both the qualitative and quantitative aspects have been covered under the report. The biodefense market report includes market size, drivers, restraints, opportunities and trends that will help you understand the market dynamics in detail. Moreover, the report will include market estimates & forecasts in terms of revenue for the overall market along with the segments mentioned in the study. The report focuses on providing a holistic view of the entire market scenario from multiple unmatched detailed analysis mentioned in the report.
What to expect from the report?
Biodefense Total Available Market (TAM) Size
Biodefense Serviceable Available Market (SAM) Size
Business Implications of COVID-19 on the Overall Market
Market Share/ Revenue Share (%) of Top Market Players in Total Market Size (2021)
Market Size & Forecast (2018-2029) At Country & Regional Level, By Segments
Overview & Analysis of Key Players Operating in the Market
Global market revenue in 2021 will be derived taking into various micro & macro level factors; along with COVID-19 pandemic
Competitive Analysis
Company Market Share Analysis, 2021 (%)
Supply Chain Analysis
Analysis pertaining to several participants of supply chain such as raw material suppliers, distributors, & OEMs along with others will be highlighted in the study
Data Source
Primary & Secondary Research, Internal Data Base & Company Annual Reports
Regions Included
North America, Europe, Asia Pacific, Latin America, & Middle East & Africa
Countries Included
U.S., Canada, U.K., Germany, France, Mexico, Brazil, China, India, Japan, South Korea, UAE, South Africa
Table of Contents
Chapter 1. Research Methodology & Data Sources
1.1. Data Analysis Models
1.2. Research Scope & Assumptions
1.3. List of Primary & Secondary Data Sources
Chapter 2. Executive Summary
Chapter 3. Biodefense Market: Industry Analysis
3.1. Market segmentation
3.2. Supply chain analysis
3.3. Porter’s 5 forces analysis
3.4. PEST analysis
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.2. Market restraint analysis
3.5.3. Market opportunity analysis
3.6. Company Market Share Analysis, 2021
Chapter 4. Biodefense Market: Product Insights
4.1. Global Product Historic Market Data & Future Forecasts, 2018-2029
4.2. Anthrax
4.2.1. Historic Market Data & Future Forecasts, 2018-2029
4.2.2. Historic Market Data & Future Forecasts by Region, 2018-2029
4.3. Small pox
4.3.1. Historic Market Data & Future Forecasts, 2018-2029
4.3.2. Historic Market Data & Future Forecasts by Region, 2018-2029
4.4. Botulism
4.4.1. Historic Market Data & Future Forecasts, 2018-2029
4.4.2. Historic Market Data & Future Forecasts by Region, 2018-2029
4.5. Radiation/nuclear
4.5.1. Historic Market Data & Future Forecasts, 2018-2029
4.5.2. Historic Market Data & Future Forecasts by Region, 2018-2029
4.6. Others
4.6.1. Historic Market Data & Future Forecasts, 2018-2029
4.6.2. Historic Market Data & Future Forecasts by Region, 2018-2029
Chapter 5. Biodefense Market: Regional Insights
5.1. Global Biodefense Market Data & Future Forecasts, By Region 2018-2029
5.2. North America
5.2.1. Historic Market Data & Future Forecasts, 2018-2029
5.2.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.2.3. U.S.
5.2.3.1. Historic Market Data & Future Forecasts, 2018-2029
5.2.3.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.2.4. Canada
5.2.4.1. Historic Market Data & Future Forecasts, 2018-2029
5.2.4.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.3. Europe
5.3.1. Historic Market Data & Future Forecasts, 2018-2029
5.3.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.3.3. U.K.
5.3.3.1. Historic Market Data & Future Forecasts, 2018-2029
5.3.3.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.3.4. Germany
5.3.4.1. Historic Market Data & Future Forecasts, 2018-2029
5.3.4.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.3.5. France
5.3.5.1. Historic Market Data & Future Forecasts, 2018-2029
5.3.5.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.4. Asia Pacific
5.4.1. Historic Market Data & Future Forecasts, 2018-2029
5.4.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.4.3. China
5.4.3.1. Historic Market Data & Future Forecasts, 2018-2029
5.4.3.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.4.4. India
5.4.4.1. Historic Market Data & Future Forecasts, 2018-2029
5.4.4.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.4.5. Japan
5.4.5.1. Historic Market Data & Future Forecasts, 2018-2029
5.4.5.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.4.6. South Korea
5.4.6.1. Historic Market Data & Future Forecasts, 2018-2029
5.4.6.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.5. Latin America
5.5.1. Historic Market Data & Future Forecasts, 2018-2029
5.5.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.5.3. Brazil
5.5.3.1. Historic Market Data & Future Forecasts, 2018-2029
5.5.3.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.5.4. Mexico
5.5.4.1. Historic Market Data & Future Forecasts, 2018-2029
5.5.4.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.6. Middle East & Africa
5.6.1. Historic Market Data & Future Forecasts, 2018-2029
5.6.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.6.3. UAE
5.6.3.1. Historic Market Data & Future Forecasts, 2018-2029
5.6.3.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.6.4. South Africa
5.6.4.1. Historic Market Data & Future Forecasts, 2018-2029
5.6.4.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
Chapter 6. Company Profiles
6.1. Dynavax Technologies Corporation
6.1.1. Company Description
6.1.2. Financial Highlights
6.1.3. Product Portfolio
6.1.4. Strategic Initiatives
6.2. Bavarian Nordic
6.2.1. Company Description
6.2.2. Financial Highlights
6.2.3. Product Portfolio
6.2.4. Strategic Initiatives
6.3. Altimune, Inc. (PharmAthene, Inc.)
6.3.1. Company Description
6.3.2. Financial Highlights
6.3.3. Product Portfolio
6.3.4. Strategic Initiatives
6.4. Cleveland Biolabs
6.4.1. Company Description
6.4.2. Financial Highlights
6.4.3. Product Portfolio
6.4.4. Strategic Initiatives
6.5. SIGA Technologies, Inc.
6.5.1. Company Description
6.5.2. Financial Highlights
6.5.3. Product Portfolio
6.5.4. Strategic Initiatives
6.6. Dynport Vaccine Company LLC
6.6.1. Company Description
6.6.2. Financial Highlights
6.6.3. Product Portfolio
6.6.4. Strategic Initiatives
6.7. Xoma Corporation
6.7.1. Company Description
6.7.2. Financial Highlights
6.7.3. Product Portfolio
6.7.4. Strategic Initiatives
6.8. B.Ichor Medical Systems
6.8.1. Company Description
6.8.2. Financial Highlights
6.8.3. Product Portfolio
6.8.4. Strategic Initiatives
6.9. Elusys Therapeutics, Inc.
6.9.1. Company Description
6.9.2. Financial Highlights
6.9.3. Product Portfolio
6.9.4. Strategic Initiatives
6.10. Emergent Biosolutions Inc.
6.10.1. Company Description
6.10.2. Financial Highlights
6.10.3. Product Portfolio
6.10.4. Strategic Initiatives
List of Tables
Table 1 Biodefense Market Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 2 Biodefense Market Data & Future Forecasts, By Region, 2018-2029 (USD Billion)
Table 3 Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 4 Anthrax Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 5 Small pox Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 6 Botulism Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 7 Radiation/nuclear Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 8 Others Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 9 North America Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 10 North America Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 11 U.S. Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 12 U.S. Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 13 Canada Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 14 Canada Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 15 Europe Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 16 Europe Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 17 U.K. Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 18 U.K Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 19 Germany Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 20 Germany Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 21 France Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 22 France Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 23 Asia Pacific Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 24 Asia Pacific Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 25 China Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 26 China Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 27 India Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 28 India Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 29 Japan Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 30 Japan Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 31 South Korea Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 32 South Korea Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 33 Latin America Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 34 Latin America Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 35 Brazil Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 36 Brazil Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 37 Mexico Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 38 Mexico Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 39 Middle East & Africa Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 40 Middle East & Africa Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 41 UAE Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 42 UAE Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 43 South Africa Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 44 South Africa Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
List of Figures
Fig.1 Data Analysis Model
Fig.2 Biodefense Market, by 2018-2029 (USD Billion)
Fig.3 Biodefense Market Segmentation
Fig.4 Supply chain analysis
Fig.5 Biodefense Market Driver Anlaysis
Fig.6 Biodefense Market Restraint Analysis
Fig.7 Biodefense Market Opportunity Analysis
Fig.8 Porters 5 Forces Model
Fig.9 PEST Analysis- Biodefense Market
Fig.10 Company Market Share Analysis, 2021
Biodefense market garnered a revenue of USD 6.3 billion in the year 2021 globally and has been foreseen to yield USD 7.9 billion by the year 2029 at a compound annual growth (CAGR) of 4.0% over the forecast period. The market has been observed to be growing at a steady growth rate over the last three years, however with the impact of COVID-19 pandemic globally, the business conditions are expected to change. The market size may reduce significantly or increase with a spike depending on how the value chain has been affected in the entire process.
Players that are operational in the market for a longer period of time are anticipated to absorb the sudden changes, losses and increased operational costs better than those who have recently entered the market. The report focuses on numerous factors that are anticipated to impact the market growth directly and indirectly. The report categorically analyses the growth patterns of different segments based on multiple derivation models.
Both the qualitative and quantitative aspects have been covered under the report. The biodefense market report includes market size, drivers, restraints, opportunities and trends that will help you understand the market dynamics in detail. Moreover, the report will include market estimates & forecasts in terms of revenue for the overall market along with the segments mentioned in the study. The report focuses on providing a holistic view of the entire market scenario from multiple unmatched detailed analysis mentioned in the report.
What to expect from the report?
Biodefense Total Available Market (TAM) Size
Biodefense Serviceable Available Market (SAM) Size
Business Implications of COVID-19 on the Overall Market
Market Share/ Revenue Share (%) of Top Market Players in Total Market Size (2021)
Market Size & Forecast (2018-2029) At Country & Regional Level, By Segments
Overview & Analysis of Key Players Operating in the Market
Global market revenue in 2021 will be derived taking into various micro & macro level factors; along with COVID-19 pandemic
Competitive Analysis
Company Market Share Analysis, 2021 (%)
Supply Chain Analysis
Analysis pertaining to several participants of supply chain such as raw material suppliers, distributors, & OEMs along with others will be highlighted in the study
Data Source
Primary & Secondary Research, Internal Data Base & Company Annual Reports
Regions Included
North America, Europe, Asia Pacific, Latin America, & Middle East & Africa
Countries Included
U.S., Canada, U.K., Germany, France, Mexico, Brazil, China, India, Japan, South Korea, UAE, South Africa
Table of Contents
Chapter 1. Research Methodology & Data Sources
1.1. Data Analysis Models
1.2. Research Scope & Assumptions
1.3. List of Primary & Secondary Data Sources
Chapter 2. Executive Summary
Chapter 3. Biodefense Market: Industry Analysis
3.1. Market segmentation
3.2. Supply chain analysis
3.3. Porter’s 5 forces analysis
3.4. PEST analysis
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.2. Market restraint analysis
3.5.3. Market opportunity analysis
3.6. Company Market Share Analysis, 2021
Chapter 4. Biodefense Market: Product Insights
4.1. Global Product Historic Market Data & Future Forecasts, 2018-2029
4.2. Anthrax
4.2.1. Historic Market Data & Future Forecasts, 2018-2029
4.2.2. Historic Market Data & Future Forecasts by Region, 2018-2029
4.3. Small pox
4.3.1. Historic Market Data & Future Forecasts, 2018-2029
4.3.2. Historic Market Data & Future Forecasts by Region, 2018-2029
4.4. Botulism
4.4.1. Historic Market Data & Future Forecasts, 2018-2029
4.4.2. Historic Market Data & Future Forecasts by Region, 2018-2029
4.5. Radiation/nuclear
4.5.1. Historic Market Data & Future Forecasts, 2018-2029
4.5.2. Historic Market Data & Future Forecasts by Region, 2018-2029
4.6. Others
4.6.1. Historic Market Data & Future Forecasts, 2018-2029
4.6.2. Historic Market Data & Future Forecasts by Region, 2018-2029
Chapter 5. Biodefense Market: Regional Insights
5.1. Global Biodefense Market Data & Future Forecasts, By Region 2018-2029
5.2. North America
5.2.1. Historic Market Data & Future Forecasts, 2018-2029
5.2.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.2.3. U.S.
5.2.3.1. Historic Market Data & Future Forecasts, 2018-2029
5.2.3.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.2.4. Canada
5.2.4.1. Historic Market Data & Future Forecasts, 2018-2029
5.2.4.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.3. Europe
5.3.1. Historic Market Data & Future Forecasts, 2018-2029
5.3.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.3.3. U.K.
5.3.3.1. Historic Market Data & Future Forecasts, 2018-2029
5.3.3.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.3.4. Germany
5.3.4.1. Historic Market Data & Future Forecasts, 2018-2029
5.3.4.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.3.5. France
5.3.5.1. Historic Market Data & Future Forecasts, 2018-2029
5.3.5.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.4. Asia Pacific
5.4.1. Historic Market Data & Future Forecasts, 2018-2029
5.4.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.4.3. China
5.4.3.1. Historic Market Data & Future Forecasts, 2018-2029
5.4.3.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.4.4. India
5.4.4.1. Historic Market Data & Future Forecasts, 2018-2029
5.4.4.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.4.5. Japan
5.4.5.1. Historic Market Data & Future Forecasts, 2018-2029
5.4.5.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.4.6. South Korea
5.4.6.1. Historic Market Data & Future Forecasts, 2018-2029
5.4.6.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.5. Latin America
5.5.1. Historic Market Data & Future Forecasts, 2018-2029
5.5.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.5.3. Brazil
5.5.3.1. Historic Market Data & Future Forecasts, 2018-2029
5.5.3.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.5.4. Mexico
5.5.4.1. Historic Market Data & Future Forecasts, 2018-2029
5.5.4.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.6. Middle East & Africa
5.6.1. Historic Market Data & Future Forecasts, 2018-2029
5.6.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.6.3. UAE
5.6.3.1. Historic Market Data & Future Forecasts, 2018-2029
5.6.3.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
5.6.4. South Africa
5.6.4.1. Historic Market Data & Future Forecasts, 2018-2029
5.6.4.2. Historic Market Data & Future Forecasts, By Product, 2018-2029
Chapter 6. Company Profiles
6.1. Dynavax Technologies Corporation
6.1.1. Company Description
6.1.2. Financial Highlights
6.1.3. Product Portfolio
6.1.4. Strategic Initiatives
6.2. Bavarian Nordic
6.2.1. Company Description
6.2.2. Financial Highlights
6.2.3. Product Portfolio
6.2.4. Strategic Initiatives
6.3. Altimune, Inc. (PharmAthene, Inc.)
6.3.1. Company Description
6.3.2. Financial Highlights
6.3.3. Product Portfolio
6.3.4. Strategic Initiatives
6.4. Cleveland Biolabs
6.4.1. Company Description
6.4.2. Financial Highlights
6.4.3. Product Portfolio
6.4.4. Strategic Initiatives
6.5. SIGA Technologies, Inc.
6.5.1. Company Description
6.5.2. Financial Highlights
6.5.3. Product Portfolio
6.5.4. Strategic Initiatives
6.6. Dynport Vaccine Company LLC
6.6.1. Company Description
6.6.2. Financial Highlights
6.6.3. Product Portfolio
6.6.4. Strategic Initiatives
6.7. Xoma Corporation
6.7.1. Company Description
6.7.2. Financial Highlights
6.7.3. Product Portfolio
6.7.4. Strategic Initiatives
6.8. B.Ichor Medical Systems
6.8.1. Company Description
6.8.2. Financial Highlights
6.8.3. Product Portfolio
6.8.4. Strategic Initiatives
6.9. Elusys Therapeutics, Inc.
6.9.1. Company Description
6.9.2. Financial Highlights
6.9.3. Product Portfolio
6.9.4. Strategic Initiatives
6.10. Emergent Biosolutions Inc.
6.10.1. Company Description
6.10.2. Financial Highlights
6.10.3. Product Portfolio
6.10.4. Strategic Initiatives
List of Tables
Table 1 Biodefense Market Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 2 Biodefense Market Data & Future Forecasts, By Region, 2018-2029 (USD Billion)
Table 3 Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 4 Anthrax Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 5 Small pox Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 6 Botulism Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 7 Radiation/nuclear Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 8 Others Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 9 North America Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 10 North America Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 11 U.S. Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 12 U.S. Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 13 Canada Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 14 Canada Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 15 Europe Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 16 Europe Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 17 U.K. Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 18 U.K Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 19 Germany Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 20 Germany Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 21 France Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 22 France Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 23 Asia Pacific Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 24 Asia Pacific Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 25 China Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 26 China Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 27 India Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 28 India Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 29 Japan Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 30 Japan Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 31 South Korea Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 32 South Korea Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 33 Latin America Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 34 Latin America Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 35 Brazil Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 36 Brazil Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 37 Mexico Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 38 Mexico Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 39 Middle East & Africa Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 40 Middle East & Africa Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 41 UAE Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 42 UAE Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
Table 43 South Africa Biodefense Market Data & Future Forecasts, 2018-2029 (USD Billion)
Table 44 South Africa Biodefense Market Data & Future Forecasts, By Product, 2018-2029 (USD Billion)
List of Figures
Fig.1 Data Analysis Model
Fig.2 Biodefense Market, by 2018-2029 (USD Billion)
Fig.3 Biodefense Market Segmentation
Fig.4 Supply chain analysis
Fig.5 Biodefense Market Driver Anlaysis
Fig.6 Biodefense Market Restraint Analysis
Fig.7 Biodefense Market Opportunity Analysis
Fig.8 Porters 5 Forces Model
Fig.9 PEST Analysis- Biodefense Market
Fig.10 Company Market Share Analysis, 2021
Biodefense Market Segmentation:
Biodefense Market, By Product (2018-2029)
Anthrax
Small pox
Botulism
Radiation/nuclear
Others
Biodefense Market, By Region (2018-2029)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Asia Pacific
China
India
Japan
South Korea
Latin America
Brazil
Mexico
Middle East & Africa
UAE
South Africa
Major Players Operating in the Biodefense Market:
Dynavax Technologies Corporation
Bavarian Nordic
Altimune, Inc. (PharmAthene, Inc.)
Cleveland Biolabs
SIGA Technologies, Inc.
Dynport Vaccine Company LLC
Xoma Corporation
Ichor Medical Systems
Elusys Therapeutics, Inc.
Emergent Biosolutions Inc.
Frequently Asked Questions About This Report
Choose License Type
Each market study on Reports Globe will be revised based on COVID-19 impact analysis
How can we help you?
Our salient features
Best Solution
We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.
Customized Research
Our team of analysts and consultants provide assistance for customized research requirements
Max ROI
Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.
24/7 Support
24X7 availability to help you through the buying process as well as answer any of your doubts.
